000			nab a22 7a 4500
999			_c16899 _d16899
003			PC16899
005			20220613134748.0
008			220613b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_92849 _aOliver Pérez, María de los Reyes _eObstetricia y ginecología
100			_92845 _aBravo Violeta, Victoria _eObstetricia y ginecología
100			_91376 _aJiménez López, Jesús Salvador _eObstetricia y Ginecología
245	0	0	_aCross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules. _h[artículo]
260			_bInfectious agent and cancer, _c2015
300			_a10:41.
500			_aFormato Vancouver: Pérez MR, Violeta VB, Del Campo AV, Ruiz C, Castaño SY, Conde LP et al. Cross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules. Infect Agent Cancer. 2015 Nov 16;10:41.
501			_aPMID: 26576200 PMC4645478
504			_aContiene 27 referencias
520			_aBackground: Although the inclusion of the HPV vaccine has been registered in Spain since 2007, vaccination rates are lower than expected. The patients wish to be vaccinated is heavily influenced by information they have received from many source. The Knowledge of primary health care professionals affects the information provided to patients and is fundamental in the decision making. The aim of this study is to assess the opinions of primary health care professionals on the vaccine against HPV and their knowledge about HPV infection and its links to with gynecological and oropharyngeal cancer. Methods: Cross-sectional study. A 19-item survey was drawn up. It included questions on basic aspects of HPV infection and marketed vaccines, personal opinion about the inclusion in the immunization schedules and their level of prescription and recommendation to patients in their clinical practice. From October 2013 to December 2013, 607 surveys were distributed among 20 primary health centers affiliated to the University Hospital 12 de Octubre. The results were analyzed using SPSS statistical package. Results: One hundred sixty four successfully completed surveys were obtained for analysis. 89 % of the professionals knew about the relationship between HPV infection and cervical cancer, 57.3 % did not know any of the serotypes against which vaccines are targeted; 40.4 % believed that there is insufficient data to support the commercialization of the vaccines. Of these, 65.7 % argue that there is no data of its long-term effectiveness, 13.4 % that there is no data as to its side effects, 13.4 % believed that the cost effectiveness is not worthwhile. Conclusions: There is a strong controversy among health professionals regarding the marketing and inclusion of HPV vaccine in immunization schedules. However, the knowledge of the primary care health professionals on key aspects of infection and vaccine protection are insufficient. The training of professionals in vaccination, cervical pathology and HPV infection should be improved to provide objective information on the use as this vaccine for patients.
710			_9427 _aServicio de Obstetricia y Ginecología
856			_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645478/ _yAcceso libre
942			_2ddc _cART _n0